Molecular Pharmacology (USA) Ltd. 10-K

MLPH FORM 10K 06-30-2013

MLPH FORM EX 31 06-30-2013

MLPH FORM EX 31 06-30-2013

MLPH FORM EX 32 06-30-2013

XBRL INSTANCE FILE - 2013-06-30

XBRL SCHEMA FILE - 2013-06-30

XBRL DEFINITION FILE - 2013-06-30

XBRL LABEL FILE - 2013-06-30

XBRL PRESENTATION FILE - 2013-06-30

IDEA: Changes in Accounting Policies

IDEA: Nature and Continuance of Operations

IDEA: XBRL DOCUMENT

IDEA: XBRL DOCUMENT

IDEA: XBRL DOCUMENT

IDEA: XBRL DOCUMENT

IDEA: XBRL DOCUMENT

IDEA: XBRL DOCUMENT

IDEA: Subsequent Event

IDEA: Recent Accounting Pronouncements

IDEA: Due to Related Parties and Related Party Transactions

IDEA: XBRL DOCUMENT

IDEA: XBRL DOCUMENT

IDEA: Accounts Payable and Accrued Liabilities

IDEA: XBRL DOCUMENT

IDEA: Segmented Information

IDEA: Balance Sheets

IDEA: XBRL DOCUMENT

IDEA: Equipment

IDEA: Shareholders Equity

IDEA: XBRL DOCUMENT

IDEA: Statements of Cash Flows

IDEA: XBRL DOCUMENT

IDEA: XBRL DOCUMENT

IDEA: XBRL DOCUMENT

IDEA: XBRL DOCUMENT

IDEA: XBRL DOCUMENT

IDEA: Significant Accounting Policies

IDEA: Supplemental Disclosures with Respect to Cash Flows

IDEA: Income Taxes

IDEA: Financial Instruments

IDEA: Statements of Operations

IDEA: XBRL DOCUMENT

IDEA: XBRL DOCUMENT

IDEA: XBRL DOCUMENT

IDEA: XBRL DOCUMENT

IDEA: XBRL DOCUMENT

IDEA: Capital Stock

IDEA: XBRL DOCUMENT

IDEA: XBRL DOCUMENT

IDEA: Distribution Agreement

IDEA: XBRL DOCUMENT

IDEA: Document and Entity Information